1. Signaling Pathways
  2. TGF-beta/Smad
  3. TGF-β Receptor
  4. TGF-β Receptor Inhibitors

TGF-β Receptor Inhibitors

ALK1

ALK2

ALK3

ALK4

ALK5

ALK6

ALK7

TGFβR2

ACVR2A

ACVR2B

BMP

GDF15

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

TGF-β Receptor Inhibitors, Agonists, Antagonists, Activators & Degraders
Product Name ALK1 ALK2 ALK3 ALK4 ALK5 ALK6 ALK7 TGFβR2 ACVR2A ACVR2B BMP GDF15 Purity
SB-431542      
ALK4, IC50: 1 μM
ALK5, IC50: 0.75 μM
 
ALK7, IC50: 2 μM
          99.85%
A 83-01      
ALK4, IC50: 45 nM
ALK5, IC50: 12 nM
 
ALK7, IC50: 7.5 nM
          99.41%
Dorsomorphin  
ACVR1
BMPR1A
   
ALK6
            99.91%
LDN193189  
ACVR1, IC50: 5 nM
BMPR1A, IC50: 30 nM
                  99.72%
THR-123 TFA    
BMPR1A
                 
Dorsomorphin dihydrochloride  
ACVR1
BMPR1A
   
ALK6
            99.91%
RepSox        
ALK5, IC50: 4 nM
              99.92%
Bimagrumab                
ACVR2A, Kd: 434 pM
ACVR2B, Kd: 1.7 pM
    99.31%
Ponsegromab                      
GDF15
99.60%
Vactosertib        
ALK5, IC50: 12.9 nM
              99.53%
LDN193189 Tetrahydrochloride  
ACVR1, IC50: 5 nM
BMPR1A, IC50: 30 nM
                  99.79%
A 83-01 sodium      
ALK4, IC50: 45 nM
ALK5, IC50: 12 nM
 
ALK7, IC50: 7.5 nM
          98.03%
Sotatercept                
ACVR2A
      99.94%
N-Acetyltaurine                      
GDF15
99.91%
SB-431542 (GMP)      
ALK4, IC50: 1 μM
ALK5, IC50: 0.75 μM
 
ALK7, IC50: 2 μM
         
Visugromab                      
GDF15
98.40%
LDN-214117
ALK1, IC50: 27 nM
ACVR1, IC50: 24 nM
BMPR1A, IC50: 1171 nM
 
ALK5, IC50: 3000 nM
              99.54%
GLPG3312                
ACVR2A, IC50: 860 nM
      98.63%
LDN-212854
ALK1, IC50: 2.4 nM
ACVR1, IC50: 1.3 nM
BMPR1A, IC50: 85.8 nM
ALK4, IC50: 2133 nM
ALK5, IC50: 9276 nM
              99.62%
ML347
ALK1, IC50: 46 nM
ACVR1, IC50: 32 nM
BMPR1A, IC50: 10800 nM
                  99.94%
R-268712        
TGFBR1, IC50: 2.5 nM
              99.92%
Vactosertib Hydrochloride        
ALK5, IC50: 12.9 nM
              99.22%
Fidrisertib
ALK1, IC50: 3 nM
ALK2 R206H, IC50: 0.2 nM
ALK2, IC50: 0.6 nM
 
ALK4, IC50: 65 nM
ALK5, IC50: 155 nM
ALK6, IC50: 24 nM
 
TGF-βR2, IC50: 67 nM
ACVR2A, IC50: 9096 nM
      98.58%
THRX-144644        
ALK5, IC50: 0.14 nM
              99.90%
Ontunisertib        
ALK5
              99.95%
Zilurgisertib  
ALK2, IC50: 15 nM
                    98.25%
IN-1130        
ALK5
              99.93%
OD36  
ACVR1, Kd: 37 nM
ACVR1, IC50: 47 nM
ALK2 R206H, IC50: 22 nM
                    99.33%
EW-7195        
ALK5, IC50: 4.83 nM
              98.84%
A 83-01 (Standard)      
ALK4, IC50: 45 nM
ALK5, IC50: 12 nM
 
ALK7, IC50: 7.5 nM
         
AZ12601011      
ALK4
   
ALK7
          99.78%
ALK2-IN-2  
ACVR1, IC50: 9 nM
                    99.93%
Itacnosertib  
ACVR1, IC50: 8 nM
                    99.06%
AZ12799734
ALK1, Kd: 7.1 μM
ACVR1, Kd: 6.2 μM
BMPR1A, Kd: 40 μM
ALK4, Kd: 1 μM
ALK5, Kd: 0.74 μM
TGFBR1, IC50: 47 nM
ALK6, Kd: 0.017 μM
            98.67%
Nisevokitug              
TGF-βR2
       
Rilogrotug                      
GDF15
99.9%
KER047  
ALK2
                    98.80%
Itacnosertib hydrochloride  
ACVR1, IC50: 8 nM
                    99.43%
KER047 succinate  
ALK2
                    98.93%
BI-4659        
TGFBR1, IC50: 19 nM
              99.78%
M4K-2009  
ALK2
                    99.35%
ALK5-IN-34        
ALK5, IC50: <10 nM
              98.21%
AMPK activator 12                      
GDF15
99.68%
CDD-2789
ALK1, Kd: 3.9 nM
ALK1, IC50: 10.07 μM
ALK2, Kd: 2.1 nM
ACVR1, IC50: 0.54 μM
BMPR1A, Kd: 541 nM
 
TGFBR1, Kd: 847 nM
ALK6, Kd: 254 nM
           
TGFβRII-IN-3              
TGF-βR2, IC50: 4.1 μM
        99.51%
OD36 hydrochloride  
ACVR1, Kd: 37 nM
ACVR1, IC50: 47 nM
ALK2 R206H, IC50: 22 nM
                   
Gdf15 Mouse Pre-designed siRNA Set A                      
GDF15
GDF15 Human Pre-designed siRNA Set A                      
GDF15
M4K2281  
ALK2, IC50: 2 nM
   
ALK5, IC50: 350 nM
             
THR-123    
BMPR1A
                 
ALK5-IN-33        
ALK5, IC50: ≤10 nM
             
J-1149        
ALK5, IC50: 0.017 μM
             
YXX0248                      
GDF15
RKER-216  
ACVR1, Kd: 58.7 pM
                   
Visugromab (Powder)                      
GDF15
ActRIIB-IN-2                  
ACVR2B, IC50: 1.1 nM
   
TGFβRII-IN-2              
TGF-βR2, IC50: 2.4 μM
       
ALK5-IN-85        
ALK5, IC50: <100 nM
             
ALK5-IN-25        
ALK5, IC50: ≤10 nM
             
M4K2308  
ALK2, IC50: 2 nM
   
ALK5, IC50: 224 nM
             
MU1700
ALK1, IC50: 13 nM
ALK2, IC50: 6 nM
     
ALK6, IC50: 41 nM
           
ALK5-IN-27        
ALK5, IC50: ≤10 nM
             
HM-279
ALK1, IC50: 21.0 nM
ALK2, IC50: 64.7 nM
BMPR1A, IC50: 269 nM
ALK4, IC50: 34.6 nM
ALK5, IC50: 4.7 nM
ALK6, IC50: 999 nM
ALK7, IC50: 6.8 nM
 
ACVR2A, IC50: 671 nM
ACVR2B, IC50: 364 nM
   
J-1063        
ALK5
             
ALK5-IN-28        
ALK5, IC50: ≤10 nM
             
M4K2306  
ALK2, IC50: 7 nM
   
ALK5, IC50: 3915 nM
             
ALK2-IN-6  
ALK2, IC50: 9 nM
                   
YXX0237                      
GDF15
DMH-1 (GMP)                    
BMP
 
Gdf15 Rat Pre-designed siRNA Set A                      
GDF15
N-Acetyltaurine hemimagnesium                      
GDF15